CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED

Related Directorships

Officer	Related Company	Role	Date Appointed	Role Status	Incorporation date	Company Status
PAUL MARTIN DOYLE	PEAKDALE CHEMISTRY SERVICES LIMITED	Director	2014-07-05	CURRENT	2009-10-16	Active
PAUL MARTIN DOYLE	PEAKDALE PROPERTIES LIMITED	Director	2012-03-13	CURRENT	2012-03-13	Dissolved 2015-06-09
MICHAEL JOHN FORT	AQUILA BIOMEDICAL LIMITED	Director	2017-10-23	CURRENT	2011-02-21	Active
MICHAEL JOHN FORT	RESOURCE AND ENVIRONMENTAL CONSULTANTS LIMITED	Director	2015-12-04	CURRENT	1995-12-04	Liquidation
MICHAEL JOHN FORT	REC ASBESTOS (SOUTH) LIMITED	Director	2015-12-04	CURRENT	1999-08-23	Active - Proposal to Strike off
MICHAEL JOHN FORT	RESOURCE & ENVIRONMENTAL CONSULTANTS (ASBESTOS) LIMITED	Director	2015-12-04	CURRENT	2002-11-14	Active - Proposal to Strike off
MICHAEL JOHN FORT	PEAKDALE CHEMISTRY SERVICES LIMITED	Director	2015-12-04	CURRENT	2009-10-16	Active
MICHAEL JOHN FORT	SAL FOOD LIMITED	Director	2015-12-04	CURRENT	2010-06-23	Active - Proposal to Strike off
MICHAEL JOHN FORT	REC ENVIRONMENTAL MONITORING LTD	Director	2015-12-04	CURRENT	2012-12-31	Active - Proposal to Strike off
MICHAEL JOHN FORT	SAL LABORATORIES LIMITED	Director	2015-12-04	CURRENT	1984-01-04	Active - Proposal to Strike off
MICHAEL JOHN FORT	SGS CAMBRIDGE LIMITED	Director	2015-12-04	CURRENT	1990-06-22	Active
MICHAEL JOHN FORT	NOBLE ASBESTOS CONSULTANCY LIMITED	Director	2015-12-04	CURRENT	2002-10-14	Active - Proposal to Strike off
MICHAEL JOHN FORT	CXR BIOSCIENCES LIMITED	Director	2015-12-04	CURRENT	2000-10-09	Active
MICHAEL JOHN FORT	AGENDA 1 ANALYTICAL SERVICES LIMITED	Director	2015-10-15	CURRENT	2006-08-11	Active - Proposal to Strike off
MICHAEL JOHN FORT	SCIENTIFIC ANALYSIS LABORATORIES LIMITED	Director	2015-10-14	CURRENT	2015-09-10	Active
MICHAEL JOHN FORT	PEAKDALE MOLECULAR LIMITED	Director	2015-08-10	CURRENT	2015-06-17	Active
MICHAEL JOHN FORT	M.J. FORT AND ASSOCIATES LIMITED	Director	2014-06-10	CURRENT	2014-05-15	Active
MICHAEL JOHN FORT	CONCEPT LIFE SCIENCES LIMITED	Director	2014-06-05	CURRENT	2014-06-02	Active
MICHAEL JOHN FORT	CONCEPT LIFE SCIENCES (MIDCO) LIMITED	Director	2014-06-02	CURRENT	2014-05-19	Active
MICHAEL JOHN FORT	CONCEPT LIFE SCIENCES (LABORATORIES) LIMITED	Director	2014-06-02	CURRENT	2014-05-19	Active
MICHAEL JOHN FORT	CONCEPT LIFE SCIENCES (ENVIRONMENTAL CONSULTING) LIMITED	Director	2014-06-02	CURRENT	2014-05-19	Active
MICHAEL JOHN FORT	CONCEPT LIFE SCIENCES (DISCOVERY) LIMITED	Director	2014-06-02	CURRENT	2014-05-19	Active
MICHAEL JOHN FORT	CONCEPT LIFE SCIENCES (HOLDINGS) LIMITED	Director	2014-06-02	CURRENT	2014-05-19	Active
JOHN WILLIAM HANDLEY	AQUILA BIOMEDICAL LIMITED	Director	2017-10-23	CURRENT	2011-02-21	Active
JOHN WILLIAM HANDLEY	RESOURCE AND ENVIRONMENTAL CONSULTANTS LIMITED	Director	2017-08-14	CURRENT	1995-12-04	Liquidation
JOHN WILLIAM HANDLEY	SGS CAMBRIDGE LIMITED	Director	2017-08-14	CURRENT	1990-06-22	Active
JOHN WILLIAM HANDLEY	AGENDA 1 ANALYTICAL SERVICES LIMITED	Director	2017-08-14	CURRENT	2006-08-11	Active - Proposal to Strike off
PAUL MCCLUSKEY	AQUILA BIOMEDICAL LIMITED	Director	2017-10-23	CURRENT	2011-02-21	Active
PAUL MCCLUSKEY	AGENDA 1 ANALYTICAL SERVICES LIMITED	Director	2015-10-15	CURRENT	2006-08-11	Active - Proposal to Strike off
PAUL MCCLUSKEY	SCIENTIFIC ANALYSIS LABORATORIES LIMITED	Director	2015-10-14	CURRENT	2015-09-10	Active
PAUL MCCLUSKEY	CXR BIOSCIENCES LIMITED	Director	2015-08-14	CURRENT	2000-10-09	Active
PAUL MCCLUSKEY	PEAKDALE MOLECULAR LIMITED	Director	2015-08-10	CURRENT	2015-06-17	Active
PAUL MCCLUSKEY	CONCEPT LIFE SCIENCES LIMITED	Director	2015-05-21	CURRENT	2014-06-02	Active
PAUL MCCLUSKEY	PEAKDALE PROPERTIES LIMITED	Director	2014-07-05	CURRENT	2012-03-13	Dissolved 2015-06-09
PAUL MCCLUSKEY	CONCEPT LIFE SCIENCES (MIDCO) LIMITED	Director	2014-07-05	CURRENT	2014-05-19	Active
PAUL MCCLUSKEY	CONCEPT LIFE SCIENCES (LABORATORIES) LIMITED	Director	2014-07-05	CURRENT	2014-05-19	Active
PAUL MCCLUSKEY	RESOURCE AND ENVIRONMENTAL CONSULTANTS LIMITED	Director	2014-07-05	CURRENT	1995-12-04	Liquidation
PAUL MCCLUSKEY	REC ASBESTOS (SOUTH) LIMITED	Director	2014-07-05	CURRENT	1999-08-23	Active - Proposal to Strike off
PAUL MCCLUSKEY	RESOURCE & ENVIRONMENTAL CONSULTANTS (ASBESTOS) LIMITED	Director	2014-07-05	CURRENT	2002-11-14	Active - Proposal to Strike off
PAUL MCCLUSKEY	PEAKDALE CHEMISTRY SERVICES LIMITED	Director	2014-07-05	CURRENT	2009-10-16	Active
PAUL MCCLUSKEY	SAL FOOD LIMITED	Director	2014-07-05	CURRENT	2010-06-23	Active - Proposal to Strike off
PAUL MCCLUSKEY	REC ENVIRONMENTAL MONITORING LTD	Director	2014-07-05	CURRENT	2012-12-31	Active - Proposal to Strike off
PAUL MCCLUSKEY	SAL LABORATORIES LIMITED	Director	2014-07-05	CURRENT	1984-01-04	Active - Proposal to Strike off
PAUL MCCLUSKEY	SGS CAMBRIDGE LIMITED	Director	2014-07-05	CURRENT	1990-06-22	Active
PAUL MCCLUSKEY	NOBLE ASBESTOS CONSULTANCY LIMITED	Director	2014-07-05	CURRENT	2002-10-14	Active - Proposal to Strike off
PAUL MCCLUSKEY	CONCEPT LIFE SCIENCES (ENVIRONMENTAL CONSULTING) LIMITED	Director	2014-07-05	CURRENT	2014-05-19	Active
PAUL MCCLUSKEY	CONCEPT LIFE SCIENCES (DISCOVERY) LIMITED	Director	2014-07-05	CURRENT	2014-05-19	Active
PAUL MCCLUSKEY	CONCEPT LIFE SCIENCES (HOLDINGS) LIMITED	Director	2014-07-05	CURRENT	2014-05-19	Active

Job Title	Location	Job description	Date posted
Section Head	Sandwich	*The Company* Peakdale Molecular (part of the Concept Life Sciences Group) is a leading UK-based CRO, providing early phase drug discovery services to the	2016-11-29
Analytical Chemist	Sandwich	*The Company* Peakdale Molecular (part of the Concept Life Sciences Group) is a leading UK-based CRO, providing early phase drug discovery services to the	2016-11-29
Synthetic/Organic Chemist	Sandwich	*The Company* Peakdale Molecular (part of the Concept Life Sciences Group) is a leading UK-based CRO, providing early phase drug discovery services to the	2016-11-29
Synthetic/Organic Chemist	Chapel en le Frith	Benefits include flexible working hours, Bupa dental care, Bupa private healthcare, employee benefits programme, life insurance, 25 days holiday plus bank...	2016-11-29
Credit Controller & Accounts Assistant	High Peak	Benefits include flexible working hours, Bupa dental care, Bupa private healthcare, employee benefits programme, life insurance, 25 days holiday plus bank...	2016-11-14
Administrator Assistant	Sandwich	*The Company* Peakdale Molecular (operating as the Discovery and Pre-Clinical arm of Concept Life Sciences) is a leading UK-based CRO delivering a vast array	2016-09-26
Synthetic/Organic Chemist	Sandwich	*The Company* Peakdale Molecular (part of the Concept Life Sciences Group) is a leading UK-based CRO, providing early phase drug discovery services to the	2016-08-16
Synthetic Chemist	Sandwich	Peakdale Molecular is a leading UK-based CRO, part of the Concept Life Sciences Group, employing one of the largest chemistry groups in the UK. Our Sandwich	2016-05-25

Jobs results powered by Indeed

This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

Date	Document Type	Document Description
2024-04-11		CONFIRMATION STATEMENT MADE ON 31/03/24, WITH NO UPDATES
2023-12-13		Notice of agreement to exemption from audit of accounts for period ending 31/12/22
2023-12-13		Audit exemption statement of guarantee by parent company for period ending 31/12/22
2023-12-13		Consolidated accounts of parent company for subsidiary company period ending 31/12/22
2023-12-13		Audit exemption subsidiary accounts made up to 2022-12-31
2023-11-22		Audit exemption statement of guarantee by parent company for period ending 31/12/22
2023-11-22		Notice of agreement to exemption from audit of accounts for period ending 31/12/22
2023-04-24		REGISTERED OFFICE CHANGED ON 24/04/23 FROM Warwick House 25-27 Buckingham Palace Road London SW1W 0PP England
2023-04-24		CONFIRMATION STATEMENT MADE ON 31/03/23, WITH NO UPDATES
2023-04-05		REGISTERED OFFICE CHANGED ON 05/04/23 FROM Melbourne House 5th Floor, 44-46 Aldwych London WC2B 4LL England
2023-04-05		APPOINTMENT TERMINATED, DIRECTOR MARK CARNEGIE-BROWN
2023-04-05		DIRECTOR APPOINTED DR BENJAMIN CLIFF
2023-04-05		APPOINTMENT TERMINATED, DIRECTOR STEVEN BLAIR
2023-04-05		REGISTERED OFFICE CHANGED ON 05/04/23 FROM Limerston Capital 12-18 Grosvenor Gardens London SW1W 0DH England
2022-09-09		Audit exemption statement of guarantee by parent company for period ending 31/12/21
2022-09-09		Notice of agreement to exemption from audit of accounts for period ending 31/12/21
2022-09-09		Consolidated accounts of parent company for subsidiary company period ending 31/12/21
2022-09-09		Audit exemption subsidiary accounts made up to 2021-12-31
2022-09-09	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/21
2022-09-09	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/21
2022-09-09	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/21
2022-09-08		DIRECTOR APPOINTED MR STEVEN BLAIR
2022-09-08		APPOINTMENT TERMINATED, DIRECTOR STEVEN FRANCIS AXTELL HORDER
2022-09-08	TM01	APPOINTMENT TERMINATED, DIRECTOR STEVEN FRANCIS AXTELL HORDER
2022-09-08	AP01	DIRECTOR APPOINTED MR STEVEN BLAIR
2022-09-07		Director's details changed for Mr Steven Francis Axtell Horder on 2022-06-28
2022-09-07	CH01	Director's details changed for Mr Steven Francis Axtell Horder on 2022-06-28
2022-05-25	AD01	REGISTERED OFFICE CHANGED ON 25/05/22 FROM Heritage House Church Road Egham TW20 9QD England
2022-04-14	CS01	CONFIRMATION STATEMENT MADE ON 31/03/22, WITH NO UPDATES
2021-10-07	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/20
2021-10-07	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/20
2021-10-07	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/20
2021-06-22	CS01	CONFIRMATION STATEMENT MADE ON 20/06/21, WITH UPDATES
2020-12-14	SH20	Statement by Directors
2020-12-14	SH19	Statement of capital on 2020-12-14 GBP 1,372,776.90
2020-12-14	CAP-SS	Solvency Statement dated 11/12/20
2020-12-14	RES06	Resolutions passed: Resolution of reduction in issued share capital
2020-12-14	SH01	11/12/20 STATEMENT OF CAPITAL GBP 2372776.9
2020-10-02	TM01	APPOINTMENT TERMINATED, DIRECTOR MATTHEW JAMES HANSON
2020-10-02	AP01	DIRECTOR APPOINTED MR STEVEN FRANCIS AXTELL HORDER
2020-08-25	AA	FULL ACCOUNTS MADE UP TO 31/12/19
2020-07-31	AD01	REGISTERED OFFICE CHANGED ON 31/07/20 FROM One St Peter's Square Manchester M2 3DE United Kingdom
2020-06-22	CS01	CONFIRMATION STATEMENT MADE ON 20/06/20, WITH UPDATES
2020-03-11	TM01	APPOINTMENT TERMINATED, DIRECTOR PAUL MCCLUSKEY
2020-02-03	AA	FULL ACCOUNTS MADE UP TO 31/12/18
2019-10-30	TM01	APPOINTMENT TERMINATED, DIRECTOR JOHN WILLIAM HANDLEY
2019-10-09	TM01	APPOINTMENT TERMINATED, DIRECTOR PAUL MARTIN DOYLE
2019-08-20	AP01	DIRECTOR APPOINTED DR MARK CARNEGIE-BROWN
2019-08-07	AP01	DIRECTOR APPOINTED MR MATTHEW JAMES HANSON
2019-06-24	CS01	CONFIRMATION STATEMENT MADE ON 20/06/19, WITH UPDATES
2018-10-06	AA	FULL ACCOUNTS MADE UP TO 31/12/17
2018-09-06	TM01	APPOINTMENT TERMINATED, DIRECTOR MICHAEL JOHN FORT
2018-06-20	LATEST SOC	20/06/18 STATEMENT OF CAPITAL;GBP 1372776.9
2018-06-20	CS01	CONFIRMATION STATEMENT MADE ON 20/06/18, WITH UPDATES
2018-02-06	MR04	STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 023456760005
2018-02-06	MR04	STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 023456760006
2017-10-20	PSC05	Change of details for Concept Life Sciences (Discovery) Limited as a person with significant control on 2017-02-20
2017-10-19	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MICHAEL JOHN FORT / 31/08/2017
2017-10-19	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MICHAEL JOHN FORT / 20/02/2017
2017-09-01	RES15	CHANGE OF COMPANY NAME 08/12/20
2017-09-01	CERTNM	COMPANY NAME CHANGED PEAKDALE MOLECULAR LIMITED CERTIFICATE ISSUED ON 01/09/17
2017-09-01	CONNOT	NOTICE OF CHANGE OF NAME NM01 - RESOLUTION
2017-08-17	AP01	DIRECTOR APPOINTED JOHN WILLIAM HANDLEY
2017-07-11	LATEST SOC	11/07/17 STATEMENT OF CAPITAL;GBP 1372776.9
2017-07-11	CS01	CONFIRMATION STATEMENT MADE ON 20/06/17, WITH UPDATES
2017-05-30	AA	FULL ACCOUNTS MADE UP TO 31/12/16
2017-05-30	AA	FULL ACCOUNTS MADE UP TO 31/12/16
2017-02-20	AD01	REGISTERED OFFICE CHANGED ON 20/02/2017 FROM 100 BARBIROLLI SQUARE MANCHESTER M2 3AB
2017-02-20	AD01	REGISTERED OFFICE CHANGED ON 20/02/2017 FROM 100 BARBIROLLI SQUARE MANCHESTER M2 3AB
2016-09-07	LATEST SOC	07/09/16 STATEMENT OF CAPITAL;GBP 1372776.9
2016-09-07	CS01	CONFIRMATION STATEMENT MADE ON 31/07/16, WITH UPDATES
2016-08-02	AR01	20/06/16 ANNUAL RETURN FULL LIST
2016-05-12	AA	FULL ACCOUNTS MADE UP TO 31/12/15
2016-01-08	TM01	APPOINTMENT TERMINATED, DIRECTOR PAUL DOYLE
2016-01-08		Annotation
2015-12-07	AP01	DIRECTOR APPOINTED MICHAEL JOHN FORT
2015-12-07	TM01	APPOINTMENT TERMINATED, DIRECTOR ALAN STUART MORGAN
2015-09-23	AA	FULL ACCOUNTS MADE UP TO 31/12/14
2015-08-14	LATEST SOC	14/08/15 STATEMENT OF CAPITAL;GBP 5022070.413344
2015-08-14	AR01	31/07/15 FULL LIST
2015-07-21	TM01	APPOINTMENT TERMINATED, DIRECTOR RAYMOND FISHER
2015-06-24	TM02	APPOINTMENT TERMINATED, SECRETARY PAUL MCCLUSKEY
2015-03-17	MISC	SECTION 519
2015-01-07	AD01	REGISTERED OFFICE CHANGED ON 07/01/2015 FROM PEAKDALE SCIENCE PARK SHEFFIELD ROAD CHAPEL EN LE FRITH HIGH PEAK SK23 0PG
2014-11-13	LATEST SOC	13/11/14 STATEMENT OF CAPITAL;GBP 5022070.4167
2014-11-13	AR01	31/07/14 FULL LIST
2014-10-22	AP01	DIRECTOR APPOINTED DR PAUL MARTIN DOYLE
2014-10-22	AP01	DIRECTOR APPOINTED MR ALAN STUART MORGAN
2014-10-13	AP03	SECRETARY APPOINTED MR PAUL MCCLUSKEY
2014-10-13	AP01	DIRECTOR APPOINTED MR PAUL MCCLUSKEY
2014-10-13	TM01	APPOINTMENT TERMINATED, DIRECTOR CLIVE MAUDSLEY
2014-10-13	TM01	APPOINTMENT TERMINATED, DIRECTOR MICHAEL MCGOUN
2014-10-13	TM01	APPOINTMENT TERMINATED, DIRECTOR PAUL JOYCE
2014-10-13	TM01	APPOINTMENT TERMINATED, DIRECTOR PATRICK GRACEY
2014-10-13	TM01	APPOINTMENT TERMINATED, DIRECTOR WILLIAM FRASER ALLEN
2014-10-13	TM01	APPOINTMENT TERMINATED, DIRECTOR CHRISTINE FISHER
2014-10-13	TM01	APPOINTMENT TERMINATED, DIRECTOR PAUL DOYLE
2014-10-13	TM02	APPOINTMENT TERMINATED, SECRETARY CHRISTINE FISHER
2014-09-23	AA	GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/03/14
2014-09-05	SH01	05/07/14 STATEMENT OF CAPITAL GBP 1287666.95
2014-08-22	AA01	CURRSHO FROM 29/03/2015 TO 31/12/2014
2014-08-22	RES10	AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2014-08-22	RES01	ADOPT ARTICLES 10/06/2014
2014-07-30	MR04	STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE NO 3
2014-07-10	MR01	REGISTRATION OF A CHARGE / CHARGE CODE 023456760006
2014-07-08	MR01	REGISTRATION OF A CHARGE / CHARGE CODE 023456760005
2014-07-01	SH01	06/06/14 STATEMENT OF CAPITAL GBP 1203001.05
2014-07-01	SH01	06/06/14 STATEMENT OF CAPITAL GBP 1203001.05
2014-06-30	MR04	STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE NO 2
2014-06-30	MR04	STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE NO 1
2014-06-24	MR05	STATEMENT OF RELEASE / CEASE FROM CHARGE / WHOLE RELEASE / CHARGE NO 2
2014-06-24	MR05	STATEMENT OF RELEASE / CEASE FROM CHARGE / WHOLE RELEASE / CHARGE NO 1
2014-05-21	MR04	STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE NO 4
2014-05-20	AP01	DIRECTOR APPOINTED MR CLIVE STEWART MAUDSLEY
2013-09-11	AR01	31/07/13 FULL LIST
2013-07-30	AA	GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/03/13
2013-06-05	AP01	DIRECTOR APPOINTED PATRICK GRACEY
2013-06-05	TM01	APPOINTMENT TERMINATED, DIRECTOR ANGUS WHITELEY
2013-02-15	SH06	15/02/13 STATEMENT OF CAPITAL GBP 1203001
2012-11-14	AA	GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/03/12
2012-11-08	MG01	PARTICULARS OF A MORTGAGE OR CHARGE / CHARGE NO: 4
2012-08-23	AR01	31/07/12 FULL LIST
2012-08-23	AP03	SECRETARY APPOINTED MRS CHRISTINE FISHER
2012-08-23	TM01	APPOINTMENT TERMINATED, DIRECTOR GRAEME SMITH
2012-08-23	TM02	APPOINTMENT TERMINATED, SECRETARY GRAEME SMITH
2011-08-09	AR01	31/07/11 FULL LIST
2011-08-04	CH01	DIRECTOR'S CHANGE OF PARTICULARS / MR WILLIAM THOMAS FRASER ALLEN / 01/06/2011
2011-07-21	AA	GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/03/11
2011-06-09	RES01	ADOPT ARTICLES 31/03/2011
2010-08-11	AR01	31/07/10 FULL LIST
2010-08-11	CH01	DIRECTOR'S CHANGE OF PARTICULARS / CHRISTINE FISHER / 31/07/2010
2010-08-11	CH01	DIRECTOR'S CHANGE OF PARTICULARS / DR PAUL DOYLE / 31/07/2010
2010-07-28	AA	GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/03/10
2009-11-01	AA	GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/03/09
2009-08-25	363a	RETURN MADE UP TO 31/07/09; FULL LIST OF MEMBERS
2009-08-25	288c	DIRECTOR'S CHANGE OF PARTICULARS / PAUL DOYLE / 01/04/2009
2009-08-25	288c	DIRECTOR'S CHANGE OF PARTICULARS / CHRISTINE FISHER / 24/08/2009
2009-04-23	288a	DIRECTOR APPOINTED DR PAUL DOYLE
2009-01-12	123	NC INC ALREADY ADJUSTED 19/12/08
2009-01-12	RES13	TERMS IN OFFER LETTER BE APPROVED, DIRECTORS EMPOWERED TO ALLOT SHARES 19/12/2008
2009-01-12	RES10	AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2008-11-07	AA	GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/03/08
2008-09-18	363a	RETURN MADE UP TO 31/07/08; FULL LIST OF MEMBERS
2008-01-31	288b	DIRECTOR RESIGNED
2008-01-31	288b	DIRECTOR RESIGNED
2008-01-31	288a	NEW DIRECTOR APPOINTED
2008-01-31	123	NC INC ALREADY ADJUSTED 21/12/07
2008-01-31	RES04	NC INC ALREADY ADJUSTED 20/12/07
2008-01-31	RES04	NC INC ALREADY ADJUSTED 20/12/07
2008-01-31	RES04	NC INC ALREADY ADJUSTED 20/12/07
2008-01-31	RES04	NC INC ALREADY ADJUSTED 20/12/07
2008-01-31	RES04	NC INC ALREADY ADJUSTED 20/12/07
2008-01-31	RES04	NC INC ALREADY ADJUSTED 20/12/07
2008-01-31	RES04	NC INC ALREADY ADJUSTED 20/12/07
2008-01-31	RES04	NC INC ALREADY ADJUSTED 20/12/07
2008-01-31	RES04	NC INC ALREADY ADJUSTED 20/12/07
2008-01-31	RES04	NC INC ALREADY ADJUSTED 20/12/07
2008-01-31	RES04	NC INC ALREADY ADJUSTED 20/12/07
2008-01-31	RES04	NC INC ALREADY ADJUSTED 20/12/07
2008-01-31	RES04	NC INC ALREADY ADJUSTED 20/12/07
2008-01-31	RES04	NC INC ALREADY ADJUSTED 20/12/07
2008-01-31	RES04	NC INC ALREADY ADJUSTED 20/12/07
2008-01-31	RES11	DISAPPLICATION OF PRE-EMPTION RIGHTS
2008-01-31	RES04	£ NC 1250000/1305748 20/1
2007-11-06	AA	GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/03/07
2007-09-14	363s	RETURN MADE UP TO 31/07/07; NO CHANGE OF MEMBERS
2007-01-10	288a	NEW DIRECTOR APPOINTED
2006-10-12	AA	GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/03/06
2006-09-12	363s	RETURN MADE UP TO 31/07/06; FULL LIST OF MEMBERS
2006-08-02	288b	DIRECTOR RESIGNED
2006-07-28	288c	DIRECTOR'S PARTICULARS CHANGED
2006-01-05	RES04	£ NC 834997/1250000 20/1
2006-01-05	123	NC INC ALREADY ADJUSTED 20/12/05
2006-01-05	RES10	AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2006-01-05	RES11	DISAPPLICATION OF PRE-EMPTION RIGHTS
2005-12-13	AA	GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/03/05
2005-09-28	363s	RETURN MADE UP TO 31/07/05; FULL LIST OF MEMBERS
2005-09-06	288a	NEW DIRECTOR APPOINTED

We could not find any licences issued to CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED or authorisation from an industry specific regulator to operate. These may not be required.

Share this page on Facebook

No legal notices or events such as winding-up orders or proposals to strike-off have been issued

No fines or sanctions have been issued against CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED

Total # Mortgages/Charges	6
Mortgages/Charges outstanding	0
Mortgages Partially Satisifed	0
Mortgages Satisfied/Paid	6

Charge Type	Date of Charge	Charge Status	Mortgagee
	2014-07-10	Outstanding	EQUISTONE PARTNERS EUROPE LIMITED AS SECURITY TRUSTEE FOR THE BENEFICIARIES (SECURITY TRUSTEE)
	2014-07-08	Outstanding	LLOYDS BANK PLC
ALL ASSETS DEBENTURE	2012-11-01	Satisfied	RBS INVOICE FINANCE LIMITED
TRUST DEBENTURE	2001-11-19	Satisfied	CLOSE BROTHERS DEVELOPMENT VCT PLC (THE "SECURITY TRUSTEE")
LEGAL MORTGAGE	2000-09-08	Satisfied	NATIONAL WESTMINSTER BANK PLC
MORTGAGE DEBENTURE	2000-09-08	Satisfied	NATIONAL WESTMINSTER BANK PLC

We have not found any records of CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED registering or being granted any patents

CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED owns 6 domain names.

i-forge.co.uk   innovation-forge.co.uk   peakdale.co.uk   contractresearch.co.uk   peakdalechemistryservices.co.uk   peakdaleservices.co.uk  

We have not found any records of CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED registering or being granted any trademarks

We have not found government income sources for CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72190 - Other research and experimental development on natural sciences and engineering) as CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED are:

OAKLEA LTD.	£ 237,880
TRL LIMITED	£ 130,521
SGS MIS ENVIRONMENTAL LTD	£ 18,077
BUILDING RESEARCH ESTABLISHMENT LIMITED	£ 13,354
WILDKNOWLEDGE LTD	£ 8,604
FONTENERGY LTD	£ 4,300
T-CUBED LTD	£ 2,599
MARWELL WILDLIFE	£ 1,089
CAMPDEN BRI (CHIPPING CAMPDEN) LIMITED	£ 1,000
SITE ANALYTICAL SERVICES LIMITED	£ 950
DNAE GROUP HOLDINGS LIMITED	£ 8,493,738
TRL LIMITED	£ 1,750,794
BUILDING RESEARCH ESTABLISHMENT LIMITED	£ 1,586,573
MAGNOMATICS LIMITED	£ 1,000,000
GILL RESEARCH & DEVELOPMENT LIMITED	£ 996,786
EARLHAM INSTITUTE	£ 750,000
CRAWLEY CREATURES LIMITED	£ 561,896
SHEFFIELD HALLAM UNIVERSITY ENTERPRISES LTD	£ 561,104
SITE ANALYTICAL SERVICES LIMITED	£ 522,264
ALGAECYTES LIMITED	£ 520,000
DNAE GROUP HOLDINGS LIMITED	£ 8,493,738
TRL LIMITED	£ 1,750,794
BUILDING RESEARCH ESTABLISHMENT LIMITED	£ 1,586,573
MAGNOMATICS LIMITED	£ 1,000,000
GILL RESEARCH & DEVELOPMENT LIMITED	£ 996,786
EARLHAM INSTITUTE	£ 750,000
CRAWLEY CREATURES LIMITED	£ 561,896
SHEFFIELD HALLAM UNIVERSITY ENTERPRISES LTD	£ 561,104
SITE ANALYTICAL SERVICES LIMITED	£ 522,264
ALGAECYTES LIMITED	£ 520,000
DNAE GROUP HOLDINGS LIMITED	£ 8,493,738
TRL LIMITED	£ 1,750,794
BUILDING RESEARCH ESTABLISHMENT LIMITED	£ 1,586,573
MAGNOMATICS LIMITED	£ 1,000,000
GILL RESEARCH & DEVELOPMENT LIMITED	£ 996,786
EARLHAM INSTITUTE	£ 750,000
CRAWLEY CREATURES LIMITED	£ 561,896
SHEFFIELD HALLAM UNIVERSITY ENTERPRISES LTD	£ 561,104
SITE ANALYTICAL SERVICES LIMITED	£ 522,264
ALGAECYTES LIMITED	£ 520,000

No properties were found where CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED is liable for the business rates / property tax. This could be for a number of reasons.

• The council hasnt published the data
• We havent found or been able to process the councils data
• The company is part of a group of companies and another company in the group is liable for business rates
• The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
• Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.

Origin	Destination	Date	Import Code	Imported Goods classification description
		2017-03-00	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
		2017-02-00	29333910	Iproniazid "INN"; ketobemidone hydrochloride "INNM"; pyrodostigmine bromide "INN"
		2017-02-00	29333999	Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami
		2017-02-00	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
		2017-01-00	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
		2017-01-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2016-11-00	29333999	Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami
		2016-11-00	29420000	Separate chemically defined organic compounds, n.e.s.
		2016-11-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2016-11-00	28439090	Inorganic or organic compounds of precious metals, whether or not chemically defined (excl. silver and gold)
		2016-11-00	29181998	Carboxylic acids with alcohol function but without other oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. lactic acid, tartaric acid, citric acid, gluconic acid, cholic acid, 3-alpha, 12-alpha-dihydroxy-5-beta-cholan-24-oic acid "deoxycholic acid" and their salts and esters, and 2,2-bis"hydroxymethyl"propionic acid and chlorobenzilate [ISO] and 2,2-Diphenyl-2-hydroxyacetic acid (benzilic acid))
		2016-10-00	29182900	Carboxylic acids with phenol function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. salicylic acid and o-Acetylsalicylic acid, and their salts and esters)
		2016-10-00	29333999	Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami
		2016-10-00	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
		2016-10-00	29349960	Chlorprothixene (INN); thenalidine (INN) and its tartrates and maleates; furazolidone (INN); 7-aminocephalosporanic acid; salts and esters of (6R,7R)-3-acetoxymethyl-7-[(R)-2-formyloxy-2-phenylacetamido]-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 1-[2-(1,3-Dioxan-2-yl)ethyl]-2-methylpyridinium bromide
		2016-10-00	29349990	Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
		2016-10-00	29420000	Separate chemically defined organic compounds, n.e.s.
		2016-10-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2016-09-00	29349960	Chlorprothixene (INN); thenalidine (INN) and its tartrates and maleates; furazolidone (INN); 7-aminocephalosporanic acid; salts and esters of (6R,7R)-3-acetoxymethyl-7-[(R)-2-formyloxy-2-phenylacetamido]-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 1-[2-(1,3-Dioxan-2-yl)ethyl]-2-methylpyridinium bromide
		2016-08-00	29349960	Chlorprothixene (INN); thenalidine (INN) and its tartrates and maleates; furazolidone (INN); 7-aminocephalosporanic acid; salts and esters of (6R,7R)-3-acetoxymethyl-7-[(R)-2-formyloxy-2-phenylacetamido]-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 1-[2-(1,3-Dioxan-2-yl)ethyl]-2-methylpyridinium bromide
		2016-08-00	01061900	Live mammals (excl. primates, whales, dolphins and porpoises, manatees and dugongs, seals, sea lions and walruses, camels and other camelids, rabbits and hares, horses, asses, mules, hinnies, bovines, pigs, sheep and goats)
		2016-08-00	29420000	Separate chemically defined organic compounds, n.e.s.
		2016-07-00	29349960	Chlorprothixene (INN); thenalidine (INN) and its tartrates and maleates; furazolidone (INN); 7-aminocephalosporanic acid; salts and esters of (6R,7R)-3-acetoxymethyl-7-[(R)-2-formyloxy-2-phenylacetamido]-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 1-[2-(1,3-Dioxan-2-yl)ethyl]-2-methylpyridinium bromide
		2016-07-00	01061900	Live mammals (excl. primates, whales, dolphins and porpoises, manatees and dugongs, seals, sea lions and walruses, camels and other camelids, rabbits and hares, horses, asses, mules, hinnies, bovines, pigs, sheep and goats)
		2016-07-00	29321900	Heterocyclic compounds with oxygen hetero-atom[s] only, containing an unfused furan ring, whether or not hydrogenated, in the structure (excl. tetrahydrofuran, 2-furaldehyde "furfuraldehyde", furfuryl alcohol and tetrahydrofurfuryl alcohol)
		2016-07-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2016-07-00	90268080	Non-electronic instruments or apparatus for measuring or checking variables of liquids or gases, n.e.s.
		2016-06-00	29130000	Halogenated, sulphonated, nitrated or nitrosated derivatives of cyclic polymers of aldehydes or paraformaldehyde
		2016-06-00	29337900	Lactams (excl. 6-hexanelactam "epsilon-caprolactam", clobazam "INN", methyprylon "INN", and inorganic or organic compounds of mercury)
		2016-06-00	29349960	Chlorprothixene (INN); thenalidine (INN) and its tartrates and maleates; furazolidone (INN); 7-aminocephalosporanic acid; salts and esters of (6R,7R)-3-acetoxymethyl-7-[(R)-2-formyloxy-2-phenylacetamido]-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 1-[2-(1,3-Dioxan-2-yl)ethyl]-2-methylpyridinium bromide
		2016-06-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2016-05-00	29349960	Chlorprothixene (INN); thenalidine (INN) and its tartrates and maleates; furazolidone (INN); 7-aminocephalosporanic acid; salts and esters of (6R,7R)-3-acetoxymethyl-7-[(R)-2-formyloxy-2-phenylacetamido]-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 1-[2-(1,3-Dioxan-2-yl)ethyl]-2-methylpyridinium bromide
		2016-05-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2016-04-00	29329900	Heterocyclic compounds with oxygen hetero-atom[s] only (excl. compounds containing unfused furan ring, whether or not hydrogenated, in the structure, and lactones, isosafrole, 1-[1,3-benzodioxol-5-yl]propan-2-one, piperonal, safrole, tetrahydrocannabinols "all isomers", and inorganic or organic compounds of mercury)
		2016-04-00	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
		2016-04-00	29349960	Chlorprothixene (INN); thenalidine (INN) and its tartrates and maleates; furazolidone (INN); 7-aminocephalosporanic acid; salts and esters of (6R,7R)-3-acetoxymethyl-7-[(R)-2-formyloxy-2-phenylacetamido]-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 1-[2-(1,3-Dioxan-2-yl)ethyl]-2-methylpyridinium bromide
		2016-04-00	30041000	Medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale
		2016-04-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2016-04-00	29420000	Separate chemically defined organic compounds, n.e.s.
		2016-03-00	29349960	Chlorprothixene (INN); thenalidine (INN) and its tartrates and maleates; furazolidone (INN); 7-aminocephalosporanic acid; salts and esters of (6R,7R)-3-acetoxymethyl-7-[(R)-2-formyloxy-2-phenylacetamido]-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 1-[2-(1,3-Dioxan-2-yl)ethyl]-2-methylpyridinium bromide
		2016-03-00	29420000	Separate chemically defined organic compounds, n.e.s.
		2016-03-00	90268080	Non-electronic instruments or apparatus for measuring or checking variables of liquids or gases, n.e.s.
		2016-02-00	29242910	Lidocaine "INN"
		2016-02-00	29349960	Chlorprothixene (INN); thenalidine (INN) and its tartrates and maleates; furazolidone (INN); 7-aminocephalosporanic acid; salts and esters of (6R,7R)-3-acetoxymethyl-7-[(R)-2-formyloxy-2-phenylacetamido]-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 1-[2-(1,3-Dioxan-2-yl)ethyl]-2-methylpyridinium bromide
		2016-02-00	29420000	Separate chemically defined organic compounds, n.e.s.
		2016-01-00	29
		2016-01-00	29214900	Aromatic monoamines and derivatives; salts thereof (excl. aniline, toluidines, diphenylamine, 1-naphthylamine "alpha-naphthylamine", 2-naphthylamine "beta-naphthylamine" and their derivatives, and salts thereof, and amfetamine "INN", benzfetamine "INN", dexamfetamine "INN", etilamfetamine "INN", fencamfamine "INN", lefetamine "INN", levamfetamine "INN", mefenorex "INN" and phentermine "INN", and salts thereof)
		2016-01-00	29333999	Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami
		2016-01-00	29349960	Chlorprothixene (INN); thenalidine (INN) and its tartrates and maleates; furazolidone (INN); 7-aminocephalosporanic acid; salts and esters of (6R,7R)-3-acetoxymethyl-7-[(R)-2-formyloxy-2-phenylacetamido]-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 1-[2-(1,3-Dioxan-2-yl)ethyl]-2-methylpyridinium bromide
		2016-01-00	29350090	Sulphonamides (excl. 3-{1-[7-"hexadecylsulphonylamino"-1H-indole-3-yl]-3-oxo-1H, 3H-naphtho[1,8-cd]pyran-1-yl}-N,N-dimethyl-1H-indole-7-sulphonamide and metosulam "ISO")
		2016-01-00	29329900	Heterocyclic compounds with oxygen hetero-atom[s] only (excl. compounds containing unfused furan ring, whether or not hydrogenated, in the structure, and lactones, isosafrole, 1-[1,3-benzodioxol-5-yl]propan-2-one, piperonal, safrole, tetrahydrocannabinols "all isomers", and inorganic or organic compounds of mercury)
		2016-01-00	29420000	Separate chemically defined organic compounds, n.e.s.
		2016-01-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2016-01-00	70179000	Laboratory, hygienic or pharmaceutical glassware, whether or not graduated or calibrated (excl. glass having a linear coefficient of expansion <= 5 x 10 -6 per kelvin within a temperature range of 0°C to 300°C or of fused quartz or other fused silica, containers for the conveyance or packing of goods, measuring, checking or medical instruments and apparatus of chapter 90)
		2015-11-00	29420000	Separate chemically defined organic compounds, n.e.s.
		2015-11-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2015-10-00	29349990	Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
		2015-10-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2015-09-00	29420000	Separate chemically defined organic compounds, n.e.s.
		2015-08-00	29321900	Heterocyclic compounds with oxygen hetero-atom[s] only, containing an unfused furan ring, whether or not hydrogenated, in the structure (excl. tetrahydrofuran, 2-furaldehyde "furfuraldehyde", furfuryl alcohol and tetrahydrofurfuryl alcohol)
		2015-08-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2015-07-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2015-07-00	29420000	Separate chemically defined organic compounds, n.e.s.
		2015-06-01	29
		2015-06-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2015-06-00	29
		2015-06-00	29420000	Separate chemically defined organic compounds, n.e.s.
		2015-05-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2015-05-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2015-04-01	28439090	Inorganic or organic compounds of precious metals, whether or not chemically defined (excl. silver and gold)
		2015-04-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2015-04-00	28439090	Inorganic or organic compounds of precious metals, whether or not chemically defined (excl. silver and gold)
		2015-04-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2015-03-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2015-03-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2015-02-01	29321900	Heterocyclic compounds with oxygen hetero-atom[s] only, containing an unfused furan ring, whether or not hydrogenated, in the structure (excl. tetrahydrofuran, 2-furaldehyde "furfuraldehyde", furfuryl alcohol and tetrahydrofurfuryl alcohol)
		2015-02-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2015-02-00	29321900	Heterocyclic compounds with oxygen hetero-atom[s] only, containing an unfused furan ring, whether or not hydrogenated, in the structure (excl. tetrahydrofuran, 2-furaldehyde "furfuraldehyde", furfuryl alcohol and tetrahydrofurfuryl alcohol)
		2015-02-00	29420000	Separate chemically defined organic compounds, n.e.s.
		2015-01-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2015-01-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2015-01-00	29420000	Separate chemically defined organic compounds, n.e.s.
		2015-01-00	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2014-12-01	29
		2014-12-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2014-11-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2014-11-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2014-10-01	28439090	Inorganic or organic compounds of precious metals, whether or not chemically defined (excl. silver and gold)
		2014-10-01	29
		2014-10-01	29309099	Organo-sulphur compounds (excl. thiocarbamates and dithiocarbamates, thiuram mono-, di- or tetrasulphides, methionine, captafol [ISO], methamidophos [ISO], cysteine or cystine and their derivatives, thiodiglycol [INN] [2,2-thiodiethanol], DL-2-hydroxy-4-"methylthio"butyric acid, 2,2'-thiodiethyl bis[3-"3,5-di-tert-butyl-4-hydroxyphenyl"propionate], a mixture of isomers consisting of 4-methyl-2,6-bis"methylthio"-m-phenylenediamine and 2-methyl-4,6-bis"methylthio"-m-phenylenediamine and 2-(N,N-Die
		2014-10-01	29333999	Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami
		2014-10-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2014-10-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2014-09-01	29242998	Cyclic amides, incl. cyclic carbamates, and their derivatives; salts thereof (excl. ureines and their derivatives, salts thereof, 2-acetamidobenzoic acid "N-acetylanthranilic acid" and its salts, and ethinamate "INN", lidocaine "INN" and paracetamol "INN")
		2014-09-01	29331990	Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyrazole ring, whether or not hydrogenated, in the structure (excl. phenazone "antipyrin" and its derivatives and phenylbutazone "INN")
		2014-09-01	29333999	Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami
		2014-09-01	29335995	Heterocyclic compounds with nitrogen hetero-atom"s" only, containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure (excl. malonylurea "barbituric acid" and its derivatives, allobarbital "INN", amobarbital "INN", barbital "INN", butalbital "INN", butobarbital "INN", cyclobarbital "INN", methylphenobarbital "INN", pentobarbital "INN", phenobarbital "INN", secbutabarbital "INN", secobarbital "INN", vinylbital "INN", loprazolam "INN", mecloqualone "INN", methaqu
		2014-09-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2014-08-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2014-06-01	29335995	Heterocyclic compounds with nitrogen hetero-atom"s" only, containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure (excl. malonylurea "barbituric acid" and its derivatives, allobarbital "INN", amobarbital "INN", barbital "INN", butalbital "INN", butobarbital "INN", cyclobarbital "INN", methylphenobarbital "INN", pentobarbital "INN", phenobarbital "INN", secbutabarbital "INN", secobarbital "INN", vinylbital "INN", loprazolam "INN", mecloqualone "INN", methaqu
		2014-06-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2014-04-01	29039990	Halogenated derivatives of aromatic hydrocarbons (excl. chlorobenzene, o-dichlorobenzene, p-dichlorobenzene, hexachlorobenzene [ISO], DDT [ISO] "clofenotane [INN], 1,1,1-trichloro-2,2-bis[p-chlorophenyl]ethane" and 2,3,4,5,6-Pentabromoethylbenzene)
		2014-04-01	29400000	Sugars, chemically pure (excl. sucrose, lactose, maltose, glucose and fructose); sugar ethers, sugar acetals and sugar esters, and their salts (excl. natural or reproduced by synthesis, provitamins, vitamins, hormones, glycosides, vegetable alkaloids and their salts, ethers, esters and other derivatives)
		2014-04-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2014-04-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2014-03-01	29214900	Aromatic monoamines and derivatives; salts thereof (excl. aniline, toluidines, diphenylamine, 1-naphthylamine "alpha-naphthylamine", 2-naphthylamine "beta-naphthylamine" and their derivatives, and salts thereof, and amfetamine "INN", benzfetamine "INN", dexamfetamine "INN", etilamfetamine "INN", fencamfamine "INN", lefetamine "INN", levamfetamine "INN", mefenorex "INN" and phentermine "INN", and salts thereof)
		2014-03-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2014-03-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2014-02-01	29
		2014-02-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2014-02-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2014-01-01	29319090	Separate chemically defined organo-inorganic compounds (excl. organo-sulphur compounds, tributyltin compounds, tetramethyl lead, tetraethyl lead, dimethyl methylphosphonate, methylphosphonoyl difluoride "methylphosphonic difluoride", methylphosphonoyl dichloride "methylphosphonic dichloride" and those of mercury and (5-Ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl methyl methylphosphonate; bis[(5-ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl] methylphosphonate; 2,4,6-tripro
		2014-01-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2013-12-01	29124900	Aldehyde-alcohols, aldehyde-ethers, aldehyde-phenols and aldehydes with other oxygen function (excl. ethylvanillin "3-ethoxy-4-hydroxybenzaldehyde" and vanillin "4-hydroxy-3-methoxybenzaldehyde")
		2013-12-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2013-11-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2013-10-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2013-09-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2013-08-01	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
		2013-08-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2013-07-01	29349990	Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
		2013-07-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2013-06-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2013-05-01	29335995	Heterocyclic compounds with nitrogen hetero-atom"s" only, containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure (excl. malonylurea "barbituric acid" and its derivatives, allobarbital "INN", amobarbital "INN", barbital "INN", butalbital "INN", butobarbital "INN", cyclobarbital "INN", methylphenobarbital "INN", pentobarbital "INN", phenobarbital "INN", secbutabarbital "INN", secobarbital "INN", vinylbital "INN", loprazolam "INN", mecloqualone "INN", methaqu
		2013-04-01	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
		2013-04-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2013-03-01	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
		2013-02-01	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
		2013-02-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2013-01-01	28
		2013-01-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2012-12-01	29
		2012-11-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2012-08-01	29159070	Saturated acyclic monocarboxylic acids, their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives (excl. formic acid and acetic acid, mono-, di- or trichloroacetic acids, propionic acid, butanoic and pentanoic acids, palmitic, stearic and lauric acids and their salts and esters, and acetic anhydride)
		2012-08-01	29319090	Separate chemically defined organo-inorganic compounds (excl. organo-sulphur compounds, tributyltin compounds, tetramethyl lead, tetraethyl lead, dimethyl methylphosphonate, methylphosphonoyl difluoride "methylphosphonic difluoride", methylphosphonoyl dichloride "methylphosphonic dichloride" and those of mercury and (5-Ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl methyl methylphosphonate; bis[(5-ethyl-2-methyl-2-oxido-1,3,2-dioxaphosphinan-5-yl)methyl] methylphosphonate; 2,4,6-tripro
		2012-08-01	29349990	Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
		2012-08-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2012-07-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2012-06-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2012-05-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2011-09-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2011-09-01	71102900	Palladium in semi-manufactured forms
		2011-06-01	29310099
		2011-06-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2011-05-01	28439090	Inorganic or organic compounds of precious metals, whether or not chemically defined (excl. silver and gold)
		2011-05-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2011-03-01	28439090	Inorganic or organic compounds of precious metals, whether or not chemically defined (excl. silver and gold)
		2011-03-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2011-03-01	71102900	Palladium in semi-manufactured forms
		2011-02-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2011-02-01	29374000
		2011-01-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2011-01-01	28439090	Inorganic or organic compounds of precious metals, whether or not chemically defined (excl. silver and gold)
		2010-12-01	29
		2010-12-01	29221985	Amino-alcohols, their ethers and esters; salts thereof (other than those containing > one kind of oxygen function and excl. monoethanolamine, diethanolamine, triethanolamine, dextropropoxyphene "INN" and their salts, and N-ethyldiethanolamine and 2,2'-methyliminodiethanol "N-methyldiethanolamine" and 2-(N,N-Diisopropylamino)ethanol)
		2010-12-01	29224985	Amino-acids and their esters; salts thereof (excl. those containing > one kind of oxygen function, lysine and its esters, and salts thereof, and glutamic acid, anthranilic acid, tilidine "INN" and their salts and beta-alanine)
		2010-12-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2010-11-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2010-11-01	30029090	Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)
		2010-11-01	28439090	Inorganic or organic compounds of precious metals, whether or not chemically defined (excl. silver and gold)
		2010-10-01	29389090	Glycosides, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives (excl. rutoside "rutin" and its derivatives, digitalis glycosides, glycyrrhizic acid and glycyrrhizates)
		2010-10-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2010-10-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2010-09-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2010-08-01	28439090	Inorganic or organic compounds of precious metals, whether or not chemically defined (excl. silver and gold)
		2010-08-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2010-08-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2010-07-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2010-06-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2010-05-01	29280090	Organic derivatives of hydrazine or of hydroxylamine (excl. N,N-bis"2-methoxyethyl"hydroxylamine)
		2010-05-01	29309099	Organo-sulphur compounds (excl. thiocarbamates and dithiocarbamates, thiuram mono-, di- or tetrasulphides, methionine, captafol [ISO], methamidophos [ISO], cysteine or cystine and their derivatives, thiodiglycol [INN] [2,2-thiodiethanol], DL-2-hydroxy-4-"methylthio"butyric acid, 2,2'-thiodiethyl bis[3-"3,5-di-tert-butyl-4-hydroxyphenyl"propionate], a mixture of isomers consisting of 4-methyl-2,6-bis"methylthio"-m-phenylenediamine and 2-methyl-4,6-bis"methylthio"-m-phenylenediamine and 2-(N,N-Die
		2010-05-01	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
		2010-05-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2010-05-01	85234019
		2010-04-01	29221985	Amino-alcohols, their ethers and esters; salts thereof (other than those containing > one kind of oxygen function and excl. monoethanolamine, diethanolamine, triethanolamine, dextropropoxyphene "INN" and their salts, and N-ethyldiethanolamine and 2,2'-methyliminodiethanol "N-methyldiethanolamine" and 2-(N,N-Diisopropylamino)ethanol)
		2010-04-01	29333999	Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami
		2010-04-01	29337900	Lactams (excl. 6-hexanelactam "epsilon-caprolactam", clobazam "INN", methyprylon "INN", and inorganic or organic compounds of mercury)
		2010-04-01	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
		2010-03-01	29341000	Heterocyclic compounds containing an unfused thiazole ring, whether or not hydrogenated, in the structure
		2010-03-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2010-03-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
		2010-02-01	28439090	Inorganic or organic compounds of precious metals, whether or not chemically defined (excl. silver and gold)
		2010-02-01	29333999	Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami
		2010-02-01	29337900	Lactams (excl. 6-hexanelactam "epsilon-caprolactam", clobazam "INN", methyprylon "INN", and inorganic or organic compounds of mercury)
		2010-02-01	29420000	Separate chemically defined organic compounds, n.e.s.
		2010-01-01	29332990	Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused imidazole ring, whether or not hydrogenated, in the structure (excl. hydantoin and its derivatives, naphazoline hydrochloride "INNM", naphazoline nitrate "INNM", phentolamine "INN" and tolazoline hydrochloride "INNM")
		2010-01-01	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
		2010-01-01	29420000	Separate chemically defined organic compounds, n.e.s.

For goods imported into the United Kingdom, only imports originating from outside the EU are shown

The Technology Strategy Board has not awarded CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR

The European Union has not awarded CONCEPT LIFE SCIENCES INTEGRATED DISCOVERY & DEVELOPMENT SERVICES LIMITED any grants or awards.

We could not find any group structure information

• GRANTECH LIMITED
• NATURAL STONE SURFACES LTD
• PEAKDALE CHEMISTRY SERVICES LIMITED
• PROJECT 72 LLP
• WORKTOPS2GO LIMITED
• CONCEPT LIFE SCIENCES (LABORATORIES) LTD
• CONCEPT LIFE SCIENCES (MIDCO) LIMITED
• CONCEPT LIFE SCIENCES (HOLDINGS) LTD
• CONCEPT LIFE SCIENCES (DISCOVERY) LIMITED
• CONCEPT LIFE SCIENCES (ENVIRONMENTAL CONSULTING) LTD
• CONCEPT LIFE SCIENCES LIMITED
• PEAKDALE MOLECULAR LTD
• N S S HOLDINGS LIMITED
• CLS ANALYTICS LTD
• NEWSTEAD HOUSE MANAGEMENT LIMITED